Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanassios Argiris

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
The Lancet. Oncology|April 21, 2015
EGFR inhibition for recurrent or metastatic HNSCCAthanassios Argiris
Current Opinion in Oncology|May 1, 2002
Update on chemoradiotherapy for head and neck cancerAthanassios Argiris
Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2005
Induction chemotherapy for head and neck cancer: will history repeat itself?Athanassios Argiris
Critical Reviews in Oncology/Hematology|April 2, 2013
Current status and future directions in induction chemotherapy for head and neck cancerAthanassios Argiris
Frontiers in Oncology|December 5, 2019
Editorial: Advances in the Systemic Therapy and Combined Modality Approaches for Head and Neck CancerAthanassios Argiris, Lisa Licitra
Cancer Treatment and Research|March 7, 2003
Epidemiology, staging, and screening of head and neck cancerAthanassios Argiris, Cathy Eng
Lung Cancer (Amsterdam, Netherlands)|May 29, 2004
Gefitinib as first-line, compassionate use therapy in patients with advanced non-small-cell lung cancerAthanassios Argiris, Namrata Mittal
Clinical Advances in Hematology & Oncology : H&O|November 14, 2006
Emerging molecular targeted therapies in squamous cell carcinoma of the head and neckJill Gilbert, Athanassios Argiris
Cancer Prevention Research (Philadelphia, Pa.)|April 2, 2009
Targeting angiogenesis from premalignancy to metastasesJennifer R Grandis, Athanassios Argiris
JAMA|July 29, 2004
Can current treatments for advanced non-small-cell lung cancer be improved?Athanassios Argiris, Joan H Schiller
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
The Lancet. Oncology|April 21, 2015
EGFR inhibition for recurrent or metastatic HNSCCAthanassios Argiris
Current Opinion in Oncology|May 1, 2002
Update on chemoradiotherapy for head and neck cancerAthanassios Argiris
Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2005
Induction chemotherapy for head and neck cancer: will history repeat itself?Athanassios Argiris
Critical Reviews in Oncology/Hematology|April 2, 2013
Current status and future directions in induction chemotherapy for head and neck cancerAthanassios Argiris
Frontiers in Oncology|December 5, 2019
Editorial: Advances in the Systemic Therapy and Combined Modality Approaches for Head and Neck CancerAthanassios Argiris, Lisa Licitra
Cancer Treatment and Research|March 7, 2003
Epidemiology, staging, and screening of head and neck cancerAthanassios Argiris, Cathy Eng
Lung Cancer (Amsterdam, Netherlands)|May 29, 2004
Gefitinib as first-line, compassionate use therapy in patients with advanced non-small-cell lung cancerAthanassios Argiris, Namrata Mittal
Clinical Advances in Hematology & Oncology : H&O|November 14, 2006
Emerging molecular targeted therapies in squamous cell carcinoma of the head and neckJill Gilbert, Athanassios Argiris
Cancer Prevention Research (Philadelphia, Pa.)|April 2, 2009
Targeting angiogenesis from premalignancy to metastasesJennifer R Grandis, Athanassios Argiris
JAMA|July 29, 2004
Can current treatments for advanced non-small-cell lung cancer be improved?Athanassios Argiris, Joan H Schiller
Pageof 13